SPECIAL OFFER : 25% Super Discount For All !
Global Chikungunya Diagnostic & Treatment Market, By Diagnosis (ELIFA Based Assay ( IgM Based ELISA and IgG Based ELISA ), Serological Tests, Virological Tests, Others); By Treatment (Allopathy (Anti-pyretic, optimal analgesics, others), Homeopathy(Pyrognium, Rhus-Tox, Cedron, others), Ayurveda(Amrutharista, MahasudarshanaChurna, DhanvantaramGutika, others), others); By End User(Hospitals and Clinics, Academic Institutes, Research laboratories, and others); By Region (North America, Europe, Asia Pacific, and Rest of the World); Trend Analysis, Competitive Market Share & Forecast, 2021-2027
- Published Date: January 2021
- Report ID: BWC20271
- Available Format: PDF
- Page: 180
|
1. Research Framework |
|
1.1. Research Objective |
|
1.2. Product Overview |
|
1.3. Market Segmentation
|
|
2. Research Methodology |
|
2.1. Qualitative Research |
|
2.1.1. Primary & Secondary Applications |
|
2.2. Quantitative Research |
|
2.3. Market Breakdown & Data Triangulation |
|
2.3.1. Primary & Secondary Applications |
|
2.3.2. Secondary Research |
|
2.3.3. Primary Research |
|
2.4. Breakdown of Primary Research Respondents, By Region |
|
2.5. Assumption & Limitation
|
|
3. Executive Summary
|
|
4. Global Chikungunya Diagnostics & Treatment Industry Insights |
|
4.1. Industry Value Chain Analysis |
|
4.2. DROC Analysis |
|
4.2.1. Growth Drivers |
|
4.2.2. Restraints |
|
4.2.3. Opportunities |
|
4.2.4. Challenges
|
|
5. Market factor Analysis
|
|
5.1. Porter’s Five forces analysis |
|
5.1.1. Bargaining Power of Suppliers |
|
5.1.2. Bargaining Power of Buyers |
|
5.1.3. Threat of New Entrants |
|
5.1.4. Threat of Substitutes |
|
5.1.5. Intensity of Rivalry |
|
5.2. Value Chain Analysis |
|
5.3. Investment Analysis |
|
5.4. Pricing Analysis
|
|
6. Global Chikungunya Diagnostics & Treatment Market Overview
|
|
6.1. Market Size & Forecast by Value, 2017-2027 |
|
6.1.1. By Value (USD Million) |
|
6.2. Market Share & Forecast 2017-2027 |
|
6.2.1. By Diagnosis |
|
6.2.1.1. ELISA Based Assay |
|
6.2.1.1.1. IgM Based Assay |
|
6.2.1.1.2. IgG Based Assay |
|
6.2.1.2. Serological Tests |
|
6.2.1.2.1. Virological Tests |
|
6.2.1.2.2. Others |
|
6.2.2. By Treatment |
|
6.2.2.1. Allopathy |
|
6.2.2.1.1. Anti-pyretics |
|
6.2.2.1.2. Optimal Analgesics |
|
6.2.2.1.3. Others |
|
6.2.2.1.4. Homoeopathy |
|
6.2.2.1.5. Pyroginum |
|
6.2.2.1.6. Rhus-Tox |
|
6.2.2.1.7. Cedron |
|
6.2.2.1.8. Others |
|
6.2.2.2. Ayurveda |
|
6.2.2.3. Others |
|
6.2.3. By End-user |
|
6.2.3.1. Hospital and Clinics |
|
6.2.3.2. Academic Institutes |
|
6.2.3.3. Research Laboratories |
|
6.2.3.4. Others |
|
6.2.4. By Region |
|
6.2.4.1. North America |
|
6.2.4.2. Europe |
|
6.2.4.3. Asia Pacific |
|
6.2.4.4. Latin America |
|
6.2.4.5. Middle East & Africa
|
|
7. North America Chikungunya Diagnostics & Treatment Market
|
|
7.1. Market Size & Forecast by Value, 2017-2027 |
|
7.1.1. By Value (USD Million) |
|
7.2. Market Share & Forecast 2017-2027 |
|
7.2.1. By Diagnosis |
|
7.2.2. By Treatment |
|
7.2.3. By End User |
|
7.2.4. By Country |
|
7.2.4.1. U. S |
|
7.2.4.2. Canada |
|
7.2.4.3. Mexico
|
|
8. Europe Chikungunya Diagnostics & Treatment Market
|
|
8.1. Market Size & Forecast by Value, 2017-2027 |
|
8.1.1. By Value (USD Million) |
|
8.2. Market Share & Forecast 2017-2027 |
|
8.2.1. By Diagnosis |
|
8.2.2. By Treatment |
|
8.2.3. By End User |
|
8.2.4. By Country |
|
8.2.4.1. Germany |
|
8.2.4.2. The U.K. |
|
8.2.4.3. France |
|
8.2.4.4. Italy |
|
8.2.4.5. Russia |
|
8.2.4.6. Netherland |
|
8.2.4.7. Rest of Europe
|
|
9. Asia Pacific Chikungunya Diagnostics & Treatment Market
|
|
9.1. Market Size & Forecast by Value, 2017-2027 |
|
9.1.1. By Value (USD Million) |
|
9.2. Market Share & Forecast 2017-2027 |
|
9.2.1. By Diagnosis |
|
9.2.2. By Treatment |
|
9.2.3. By End User |
|
9.2.4. By Country |
|
9.2.4.1. China |
|
9.2.4.2. India |
|
9.2.4.3. Japan |
|
9.2.4.4. Australia |
|
9.2.4.5. South Korea |
|
9.2.4.6. Rest of Asia Pacific
|
|
10. Middle East & Africa Chikungunya Diagnostics & Treatment Market
|
|
10.1. Market Size & Forecast by Value, 2017-2027 |
|
10.1.1. By Value (USD Million) |
|
10.2. Market Share & Forecast 2017-2027 |
|
10.2.1. By Diagnosis |
|
10.2.2. By Treatment |
|
10.2.3. By End User |
|
10.2.4. By Country |
|
10.2.4.1. Saudi Arabia |
|
10.2.4.2. UAE |
|
10.2.4.3. Oman |
|
10.2.4.4. Kuwait |
|
10.2.4.5. Qatar |
|
10.2.4.6. Rest of the Middle East & Africa
|
|
11. Latin America Chikungunya Diagnostics & Treatment Market
|
|
11.1. Market Size & Forecast by Value, 2017-2027 |
|
11.1.1. By Value (USD Million) |
|
11.2. Market Share & Forecast 2017-2027 |
|
11.2.1. By Diagnosis |
|
11.2.2. By Treatment |
|
11.2.3. By End User |
|
11.2.4. By Country |
|
11.2.4.1. Brazil |
|
11.2.4.2. Rest of Latin America |
|
12. Competitive Landscape |
|
12.1. Company Market Ranking Analysis, 2019
|
|
13. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
|
|
13.1. Abbott Laboratories |
|
13.2. Quest Diagnostics |
|
13.3. Bio-Rad Laboratories, Inc. |
|
13.4. altona Diagnostics GmbH |
|
13.5. Taj Pharmaceuticals Limited. |
|
13.6. Genome Diagnostics Pvt. Ltd. |
|
13.7. Sanat Products Ltd. |
|
13.8. Etubics Corporation |
|
13.9. Other Prominent Player
|
|
14. Conclusion |
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.